Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Celadon Pharmaceuticals PLC has bolstered its financial position by receiving £150,000 from a recent subscription of shares, highlighting its commitment to advancing cannabis-based medicines in the UK. The company is focused on improving the quality of life for chronic pain sufferers and expanding its intellectual property in the pharmaceutical cannabis market.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.